ATE79550T1 - Die proteinabsorption verbessernde stoffe. - Google Patents
Die proteinabsorption verbessernde stoffe.Info
- Publication number
- ATE79550T1 ATE79550T1 AT88108205T AT88108205T ATE79550T1 AT E79550 T1 ATE79550 T1 AT E79550T1 AT 88108205 T AT88108205 T AT 88108205T AT 88108205 T AT88108205 T AT 88108205T AT E79550 T1 ATE79550 T1 AT E79550T1
- Authority
- AT
- Austria
- Prior art keywords
- toxic salt
- protein absorption
- improving substances
- hydroxylamine
- absorption improving
- Prior art date
Links
- 238000010521 absorption reaction Methods 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 231100000252 nontoxic Toxicity 0.000 abstract 5
- 230000003000 nontoxic effect Effects 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/054,898 US4839170A (en) | 1985-10-01 | 1987-05-28 | Protein absorption enhancing agents |
| EP88108205A EP0292908B1 (de) | 1987-05-28 | 1988-05-21 | Die Proteinabsorption verbessernde Stoffe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE79550T1 true ATE79550T1 (de) | 1992-09-15 |
Family
ID=21994232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88108205T ATE79550T1 (de) | 1987-05-28 | 1988-05-21 | Die proteinabsorption verbessernde stoffe. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4839170A (de) |
| EP (1) | EP0292908B1 (de) |
| JP (1) | JPS63297331A (de) |
| AT (1) | ATE79550T1 (de) |
| AU (1) | AU627125B2 (de) |
| CA (1) | CA1335788C (de) |
| DE (1) | DE3873825T2 (de) |
| IL (1) | IL86443A0 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3939346A1 (de) * | 1989-11-29 | 1991-06-06 | Behringwerke Ag | Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide |
| IL267689B2 (en) | 2016-12-31 | 2025-05-01 | Bioxcel Therapeutics Inc | Use of sublingual dexmedetomidine for the treatment of agitation |
| BR112020026672A2 (pt) | 2018-06-27 | 2021-03-30 | Bioxcel Therapeutics, Inc. | Formulações de filme contendo dexmedetomidina e métodos para produzi-las |
| BR112022000992A2 (pt) | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
| US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4661469A (en) * | 1984-08-08 | 1987-04-28 | Survival Technology, Inc. | t-PA composition capable of being absorbed into the blood stream and method of administration |
| US4656034A (en) * | 1985-05-20 | 1987-04-07 | Survival Technology, Inc. | Absorption enhancing agents |
| US4658830A (en) * | 1984-08-08 | 1987-04-21 | Survival Technology, Inc. | Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms |
| EP0214281B1 (de) * | 1985-03-06 | 1992-09-09 | Survival Technology, Inc. | Mittel zur absorptionsverbesserung von proteinen |
| ZA861695B (en) * | 1985-03-06 | 1986-10-29 | Survival Technology | T-pa composition and method of getting into blood stream |
-
1987
- 1987-05-28 US US07/054,898 patent/US4839170A/en not_active Expired - Fee Related
-
1988
- 1988-05-16 AU AU16164/88A patent/AU627125B2/en not_active Ceased
- 1988-05-19 IL IL86443A patent/IL86443A0/xx not_active IP Right Cessation
- 1988-05-21 AT AT88108205T patent/ATE79550T1/de not_active IP Right Cessation
- 1988-05-21 EP EP88108205A patent/EP0292908B1/de not_active Expired - Lifetime
- 1988-05-21 DE DE8888108205T patent/DE3873825T2/de not_active Expired - Fee Related
- 1988-05-27 JP JP63128547A patent/JPS63297331A/ja active Pending
- 1988-05-27 CA CA000567994A patent/CA1335788C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0292908A1 (de) | 1988-11-30 |
| DE3873825T2 (de) | 1993-06-24 |
| JPS63297331A (ja) | 1988-12-05 |
| US4839170A (en) | 1989-06-13 |
| EP0292908B1 (de) | 1992-08-19 |
| IL86443A0 (en) | 1988-11-15 |
| CA1335788C (en) | 1995-06-06 |
| AU1616488A (en) | 1988-12-01 |
| AU627125B2 (en) | 1992-08-13 |
| DE3873825D1 (de) | 1992-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE113213T1 (de) | Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen. | |
| CA1024868A (en) | Reagent and method for determining leukocytes and hemoglobin in the blood | |
| AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
| EP0191056A4 (de) | T-pa zusammensetzung und verfahren zu deren aufnahme in den blutstrom. | |
| DE3851473D1 (de) | Haarkosmetisches Präparat. | |
| DK0454898T3 (da) | Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet | |
| IE890580L (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
| DK0414078T3 (da) | Disubstituerede (quinolin-2-yl-methoxy)phenyleddikesyrederivater | |
| ATE79550T1 (de) | Die proteinabsorption verbessernde stoffe. | |
| DE3871791D1 (de) | Verwendung von homo- und copolymeren des vinylalkohols zum tablettieren von wirkstoffen. | |
| JPS5328133A (en) | Novel compound having lipidddepleting activity in blood*process for preparation thereof and pharmaceutical composition containing these | |
| DK325289A (da) | Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet | |
| ATE47829T1 (de) | 5,9-dimethylheptadecan verfahren und mittel zur bekaempfung der fleckenminiermotte leucoptera scitella. | |
| EP0214281A4 (de) | Mittel zur absorptionsverbesserung von proteinen. | |
| FR2603284B1 (fr) | Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique | |
| EP0191814A4 (de) | Absorptionsverbesserer für proteine. | |
| AU1751488A (en) | The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof | |
| FI843695A7 (fi) | Insuliini-johdannaisia, joissa B 30-asema on modifioitu, menetelmiä niiden valmistamiseksi ja niiden käyttö sekä sokeritaudin hoitoon tarkoitettuja lääkeaineita. | |
| EP0410652A3 (en) | Improvement of excretion of potassium ion by prostanoic acid derivatives | |
| AU482810B2 (en) | Reagent and method for determining leukocytes and hemoglobin inthe blood | |
| HU209389B (en) | Method for producing tetrasodium salt of 1,4,10,13-tetraoxa-7,16-diaza-cyclooctadecane-n,n'-dimalonic acid with sodium bromide content and one for producing medical preparatives containing said compound | |
| HUT61619A (en) | Method for radioimmunological derminic 5-hydroxi- 6,8,11,14-eicosatetraen- acid content of the biological samples | |
| UA8124A1 (uk) | Спосіб регенераціі н-катіоніту | |
| GT198500045A (es) | Una composicion para la higiene oral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |